Just in time to soften the blow in the upcoming budget-writing process, Idaho has received more than $350,000 as part of a Medicaid fraud settlement with pharmaceutical giant Novartis.
Of that sum, $118,661 goes straight to Idaho's Medicaid account and more than $230,000 will be deposited into the state's general fund.
The settlement resolved allegations that Novartis improperly promoted Trileptal and engaged in unlawful kickback schemes to induce physicians to prescribe the anti-epileptic drug and five other pharmaceuticals. In October, Idaho received $985,105 in a separate settlement with Norvartis. Idaho Attorney General Lawrence Wasden's Medicaid Fraud Control Unit joined with other states and the federal government in the settlement.